Cancer Genetics, Inc. to Report Third Quarter 2014 Financial Results on Monday, November 10

By Italia on October 30 2014

RUTHERFORD, NJ – October 30, 2014 – Cancer Genetics, Inc. (NasdaqCM: CGIX), an emerging leader in DNA-based cancer diagnostics, announced today that it will report third quarter 2014 financial results on Monday, November 10, 2014.  The Company will issue a press release before the market opens and will host a conference call at 8:30am Eastern […]

Continue Reading

Cancer Genetics Inc Granted Patent for Genomic Probe Set Used in Proprietary Test For Cervical and Other HPV-Associated Cancers

By Italia on October 21 2014

> Issuance of patent 8,865,882 covers four probe set used in CGI’s proprietary FISH-based HPV-Associated Cancer Test (FHACT®) > FHACT® cervical cancer detection test has potential application for more than 2 million patients per year in the United States RUTHERFORD, N.J., October 21, 2014 (GLOBE NEWSWIRE) — Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or “the Company”), […]

Continue Reading